Kindred At Home | |
1405 N Lafayette Street, Shelby, North Carolina 28150 | |
(704) 484-3294 | |
Name | Kindred At Home |
---|---|
Location | 1405 N Lafayette Street, Shelby, North Carolina |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 347317 |
Ownership Type | Proprietary |
Service Area Zip Codes | 28012, 28016, 28018, 28019, 28020, 28021, 28032, 28033, 28034, 28037, 28040, 28043, 28052, 28054, 28056, 28073, 28076, 28077, 28080, 28086, 28090, 28092, 28098, 28101, 28114, 28120, 28130, 28139, 28150, 28152, 28160, 28164, 28167, 28168, 28169, 28601, 28602, 28603, 28606, 28609, 28610, 28611, 28612, 28613, 28619, 28624, 28628, 28630, 28633, 28636, 28637, 28638, 28645, 28650, 28655, 28658, 28661, 28666, 28667, 28671, 28690, 28746, 28756, 28761, 29601, 29667, 29710 |
NPI Number | 1649203431 |
Organization Name | TOTAL CARE HOME HEALTH OF NORTH CAROLINA, LLC |
Doing Business As | CENTERWELL HOME HEALTH |
Address | 1405 N Lafayette St, Shelby, NC 28150 |
Phone Number | 704-484-3294 |
News Archive
On 22 August 2011, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 1.
Genetic Technologies Limited, through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen genetic test for assessing non-familial breast cancer risk.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that a U.S. patent has been awarded for the company's Tryton Side Branch Stent™ System.
The correct therapeutic dose is important for this commonly used painkiller, say the authors, because it is potentially fatal to give too high a dose; and too low a dose may result in more serious illness.
› Verified 8 days ago
Quality Rating: |
News Archive
On 22 August 2011, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 1.
Genetic Technologies Limited, through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen genetic test for assessing non-familial breast cancer risk.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that a U.S. patent has been awarded for the company's Tryton Side Branch Stent™ System.
The correct therapeutic dose is important for this commonly used painkiller, say the authors, because it is potentially fatal to give too high a dose; and too low a dose may result in more serious illness.
› Verified 8 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 96.5 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 98.8 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.8 | 99.6 |
How often the home health team checked patients for depression | 97.2 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 85.1 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 87.1 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 94.1 | 96.4 |
News Archive
On 22 August 2011, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 1.
Genetic Technologies Limited, through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen genetic test for assessing non-familial breast cancer risk.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that a U.S. patent has been awarded for the company's Tryton Side Branch Stent™ System.
The correct therapeutic dose is important for this commonly used painkiller, say the authors, because it is potentially fatal to give too high a dose; and too low a dose may result in more serious illness.
› Verified 8 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 77.9 | 79.6 |
How often patients got better at getting in and out of bed | 77.1 | 81.1 |
How often patients got better at bathing | 81.9 | 82.3 |
How often patients’ breathing improved | 79.7 | 82.8 |
How often patients’ wounds improved or healed after an operation | 92.3 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 73.4 | 75 |
How often home health patients had to be admitted to the hospital | 15.4 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 14.2 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 67.4 | 94 |
News Archive
On 22 August 2011, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 1.
Genetic Technologies Limited, through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen genetic test for assessing non-familial breast cancer risk.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that a U.S. patent has been awarded for the company's Tryton Side Branch Stent™ System.
The correct therapeutic dose is important for this commonly used painkiller, say the authors, because it is potentially fatal to give too high a dose; and too low a dose may result in more serious illness.
› Verified 8 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
On 22 August 2011, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 1.
Genetic Technologies Limited, through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen genetic test for assessing non-familial breast cancer risk.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that a U.S. patent has been awarded for the company's Tryton Side Branch Stent™ System.
The correct therapeutic dose is important for this commonly used painkiller, say the authors, because it is potentially fatal to give too high a dose; and too low a dose may result in more serious illness.
› Verified 8 days ago
The patient survey data of Kindred At Home is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
Percent of patients who reported that their home health team communicated well with them | 88 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 85 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 84 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 81 | 78 |
News Archive
On 22 August 2011, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 1.
Genetic Technologies Limited, through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen genetic test for assessing non-familial breast cancer risk.
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that a U.S. patent has been awarded for the company's Tryton Side Branch Stent™ System.
The correct therapeutic dose is important for this commonly used painkiller, say the authors, because it is potentially fatal to give too high a dose; and too low a dose may result in more serious illness.
› Verified 8 days ago
Atrium Health At Home Cleveland Location: 105 T R Harris Dr, Shelby, North Carolina 28150 Ratings: Phone: (704) 487-5225 | |
Kindred At Home Location: 1405 N Lafayette Street, Shelby, North Carolina 28150 Ratings: Phone: (704) 484-3294 |